{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:12Z","timestamp":1790726532094,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103450","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:27:30Z","timestamp":1774546050000},"page":"103450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision points"],"prefix":"10.1016","volume":"10","author":[{"given":"Christoph","family":"Freidel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Boehm-Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta Seth","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103450_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.006","article-title":"The central role of thrombin in bleeding disorders","volume":"38","author":"Negrier","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.103450_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231205279","article-title":"Antithrombin therapy: current state and future outlook","volume":"29","author":"Rodgers","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.103450_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2141.2007.06693.x","article-title":"Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients","volume":"138","author":"Shetty","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103450_bib4","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1182\/blood.2024027008","article-title":"Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study","volume":"145","author":"Young","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103450_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103450_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1751-553X.2011.01326.x","article-title":"Clinical multicenter evaluation of a new FXa-based antithrombin assay","volume":"33","author":"Merz","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2026.103450_bib8","first-page":"130","article-title":"Deficiencies of the natural anticoagulants\u2014novel clinical laboratory aspects of thrombophilia testing","volume":"27","author":"Bereczky","year":"2016","journal-title":"EJIFCC"},{"key":"10.1016\/j.rpth.2026.103450_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43941-x","article-title":"Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis","volume":"13","author":"Rojnik","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2026.103450_bib10","first-page":"405","article-title":"Diagnostic performance of commercial antithrombin activity assays: do we get what we expect?","volume":"126","author":"Orlando","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103450_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/hae.70045","article-title":"Global comparative antithrombin field study: impact of laboratory assay variability on the assessment of antithrombin activity measurement at fitusiran clinical decision-making points","volume":"31","author":"Chhabra","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103450_bib12","series-title":"Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline","year":"2012"},{"key":"10.1016\/j.rpth.2026.103450_bib13","series-title":"Evaluation of precision of quantitative measurement procedures; approved guideline","year":"2014"},{"key":"10.1016\/j.rpth.2026.103450_bib14","series-title":"Interference testing in clinical chemistry","year":"2018"},{"key":"10.1016\/j.rpth.2026.103450_bib15","series-title":"Measurement procedure comparison and bias estimation using patient samples","year":"2018"},{"key":"10.1016\/j.rpth.2026.103450_bib16","series-title":"Evaluation of precision performance of quantitative measurement methods; approved guideline","year":"2004"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:16:13Z","timestamp":1790723773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2475037926001081"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103450","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision points","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103450"}}